NEWS

April 8, 2020

Chiasma Enters Into Revenue Interest Financing Agreement for up to $75 Million with Healthcare Royalty Partners

April 2, 2020

RedHill Biopharma Completes Acquisition of Movantik^® from AstraZeneca

March 2, 2020

Karyopharm Announces Phase 3 BOSTON Study Meets Primary Endpoint with Significant Increase in Progression-Free Survival in Patients with Multiple Myeloma Following One to Three Prior Lines of Therapy

February 25, 2020

RedHill Biopharma Acquires Rights to Movantik^® from AstraZeneca

February 25, 2020

RedHill Biopharma Enters $115 Million Non-Dilutive Financing Agreement with HealthCare Royalty Partners

January 9, 2020

HealthCare Royalty Partners Raises $1.8 Billion

October 25, 2019

GSK receives prestigious Prix Galien USA award for SHINGRIX

September 16, 2019

Karyopharm Enters Into Royalty Agreement with Healthcare Royalty Partners for up to $150 Million

March 6, 2019

Infinity Pharmaceuticals Announces Royalty Monetization of COPIKTRA™ for $30 Million Gross Proceeds

March 1, 2019

Portola Pharmaceuticals Enters into $125 Million Loan Agreement with HealthCare Royalty Partners and Athyrium Capital Management